Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.75%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 4.55Close
$ 2.88 - $ 4.9 52-Week Range
Ticker Information
Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQARBUTUS BIOPHARMA CORP - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABUS - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 115K | 0.75% | $ 15.42M |
| 3/31/2025 | $ 121K | 1.89% | $ 6.4M |
| 12/31/2024 | $ 137K | 2.22% | $ 6.17M |
| 9/30/2024 | $ 151K | 2.24% | $ 6.74M |
| 6/30/2024 | $ 168K | 1.67% | $ 10.06M |
| 3/31/2024 | $ 305K | 2.35% | $ 12.99M |
| 12/31/2023 | $ 459K | 2.53% | $ 18.14M |
| 9/30/2023 | $ 724K | 3.26% | $ 22.24M |
| 6/30/2023 | $ 1.11M | 4.7% | $ 23.54M |
| 3/31/2023 | $ 1.42M | 4.28% | $ 33.13M |
Key Performance Insights, Last 5 Years
- ARBUTUS BIOPHARMA CORP's latest trailing twelve months (TTM) Int. Exp. % stands at 68.47%.
- Over the past 5 years, ARBUTUS BIOPHARMA CORP's average Int. Exp. % has been 16.41%.
- The median Int. Exp. % for ARBUTUS BIOPHARMA CORP during this period was 4.56%
- ARBUTUS BIOPHARMA CORP reached its highest Int. Exp. % over the past 5 years at 68.47%.
- The lowest Int. Exp. % recorded by ARBUTUS BIOPHARMA CORP in the same timeframe 0.75%
ARBUTUS BIOPHARMA CORP's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for ARBUTUS BIOPHARMA CORP is calculated as follows: Int. Exp. [ $ 4.21M ] / Revenues [ $ 6.15M ]
(=) Int. Exp. % [ 68.47% ] ABUS - Interest Expense Margin, Last 5 years
0.75%
Minimum
Jun 30, 2025
68.47%
Maximum
Sep 30, 2020
16.41%
Average
4.56%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |